Latest period
$56.2M
YoY change
+17.3%
5Y CAGR
-20.1%
Peak year (FY2020)
$163M
Latest annual
$53M
Total Assets history chart for Spruce Biosciences (SPRB) from 2018 to 2025
Latest: $53M
Total Assets growth chart for Spruce Biosciences (SPRB) from 2018 to 2025
Latest: +17.3%
Total Assets history table for Spruce Biosciences (SPRB) from 2018 to 2025
| FY2025 | $53M | +17.3% | +$7.81M | ||
| FY2024 | $45.2M | -56.5% | -$58.7M | ||
| FY2023 | $104M | +21.4% | +$18.3M | ||
| FY2022 | $85.6M | -32.3% | -$40.8M | ||
| FY2021 | $126M | -22.3% | -$36.4M | ||
| FY2020 | $163M | +3371.5% | +$158M | ||
| FY2019 | $4.69M | -1.7% | -$83K | ||
| FY2018 | $4.78M | — | — |
- FY2025$53M+17.3%
- FY2024$45.2M-56.5%
- FY2023$104M+21.4%
- FY2022$85.6M-32.3%
- FY2021$126M-22.3%
- FY2020$163M+3371.5%
- FY2019$4.69M-1.7%
- FY2018$4.78M—
Total Assets values are taken from Spruce Biosciences's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Assets at Spruce Biosciences (SPRB)
According to Spruce Biosciences's latest reported financial statements, the company's latest reported total assets is $56.2M. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and total equity for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual total assets for Spruce Biosciences (SPRB) came in at $53M – grew 17.3% year-over-year.
Spruce Biosciences total assets compound annual growth for the 2020–2025 (5 years) window is -20.1%, with a net decline across the window.
Spruce Biosciences total assets peaked at $163M in 2020; the latest annual figure is $53M in 2025 (67.4% below peak).
The record annual total assets stands at $163M, reached in 2020; the historical low of $4.69M was recorded in 2019.
Spruce Biosciences Total Assets by Year
Spruce Biosciences Total Assets 2025: $53M
Spruce Biosciences posted total assets of $53M in 2025, grew 17.3% from 2024.
Spruce Biosciences Total Assets 2024: $45.2M
In 2024, Spruce Biosciences reported total assets of $45.2M, plunged 56.5% below 2023.
Spruce Biosciences Total Assets 2023: $104M
Spruce Biosciences total assets in 2023 was $104M, grew 21.4% from 2022.
Spruce Biosciences Total Assets 2022: $85.6M
2022's total assets for Spruce Biosciences came in at $85.6M, plunged 32.3% below 2021.
Spruce Biosciences Total Assets 2021: $126M
Spruce Biosciences total assets in 2021 was $126M.
See more financial history for Spruce Biosciences (SPRB).
Sector peers by Total Assets
Healthcare peers of Spruce Biosciences (SPRB), ranked by their latest total assets
| $310B | |
| $199B | |
| $137B | |
| $134B | |
| $112B | |
| $110B | |
| $90.6B | |
| $85.4B |
- $137B
- $134B
- $112B
- $90.6B
- $85.4B
Frequently asked questions
Test yourself on SPRB
Market Cap — 10 rounds, every one of them SPRB against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Spruce Biosciences (SPRB) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.